Diener on Neurology

• Top Studies in Neurology From 2023   Christoph Diener discusses 10 top neurology studies from 2023 covering new drugs for Alzheimer's disease and advances in migraine.
  Medscape Neurology, January 04, 2024
• Fall Updates in Dementia, PD, and Stroke   Christoph Diener discusses interesting neurology studies published in October, spanning hearing loss and cognitive impairment, Parkinson's disease, and stroke.
  Medscape Neurology, November 22, 2023
• New Kids on the Block for Migraine Treatment and Prophylaxis   Hans-Christoph Diener provides an update on acute migraine treatment and migraine prophylaxis, including new data from the 2023 International Headache Congress.
  Medscape Neurology, October 17, 2023
• Recent Studies in Parkinson's, Headache, Stroke, and Obesity   Hans-Christoph Diener, MD, PhD, discusses recent studies in neurology and internal medicine.
  Medscape Neurology, September 27, 2023
• Alzheimer Disease, Spinal Cord Injury, and Back Pain Updates   Hans-Christoph Diener reviews recent data on drugs and diet in Alzheimer disease, novel agents for spinal cord injury, and cognitive behavioral therapy for back pain.
  Medscape Neurology, August 17, 2023
• Brief Updates on Dementia, Parkinson's, and MS   Hans-Christoph Diener discusses recent data on HRT and dementia, diet and Alzheimer's disease, Parkinson's and pollution, and the DISCOMS study.
  Medscape Neurology, August 01, 2023
• Neutral But Useful Studies From ESOC   Hans-Christoph Diener reviews some neutral studies presented at the 2023 European Stroke Organization Conference.
  Medscape Neurology, July 06, 2023
• Top 4 Positive Studies from ESOC 2023   Hans-Christoph Diener, MD, PhD, discusses trials with positive results presented at ESOC 2023.
  Medscape Neurology, June 21, 2023
• A Glimpse of Hope in Alzheimer's Disease?   Neurologist Hans-Christoph Diener reviews the data on new monoclonal therapies that bring hope to the treatment of Alzheimer's disease.
  Medscape Neurology, May 26, 2023
• New Migraine Drugs: What Independent Analyses Found   Hans-Christoph Diener, MD, PhD, discusses independent reviews commissioned by the International Headache Society on new drugs for acute and chronic migraine.
  Medscape Neurology, April 11, 2023
• Top Studies From the 2023 International Stroke Conference   Studies on stroke thrombectomy, statins, and imaging are among Dr Hans-Christoph Diener's top picks from the 2023 International Stroke Conference.
  Medscape Neurology, March 14, 2023
• What's New in Brain Health?   Hans-Christoph Diener, MD, PhD, discusses brain health, from headaches and COVID-19 to dementia and Parkinson's disease.
  Medscape Neurology, February 15, 2023
• The Latest Research on Vascular Diseases   Hans-Christoph Diener, MD, PhD, discusses recently published studies in the area of vascular diseases.
  Medscape Neurology, February 06, 2023
• 2022's Most Important Neurology Studies   Hans-Christoph Diener, MD, PhD, summarizes key clinical studies in neurology published in 2022.
  Medscape Neurology, December 30, 2022
• Recent Updates: Stroke, Migraine, and Dermatomyositis   Hans-Christoph Diener, MD, PhD, discusses recent studies on stroke, migraine, and dermatomyositis.
  Medscape Neurology, December 20, 2022
• Top Neurology Studies to Know   Hans-Christoph Diener, MD, PhD, discusses new research in the neurology space in September 2022.
  Medscape Neurology, December 15, 2022
• Frustrations and Victories in 5 New Neurology Studies   Dr Christoph Diener on disappointing results for monoclonal antibodies in Parkinson's disease, and more favorable findings for diabetic pain and rheumatic heart disease.
  Medscape Neurology, September 15, 2022
• Recent Neurology Data Highlight Treatments to Avoid   Although recent neurology literature brought good news for rituximab in relapsing-remitting multiple sclerosis, the results were decidedly more mixed for other treatments, says Dr Christoph Diener.
  Medscape Neurology, August 25, 2022
• The Role of Aspirin Today   Since first being synthesized in 1897, aspirin has become a staple neurologic treatment. It's time to sign the praises of this humble drug, says Dr Christoph Diener.
  Medscape Neurology, July 28, 2022
• The State of Monoclonal Antibodies for Migraine   Dr Christoph Diener on the enticing efficacy and safety of anti-CGRPs.
  Medscape Neurology, July 15, 2022